Economic burden from hematologic malignancies in Japan is substantial, impacting both healthcare systems and patients' quality of life.
The analysis utilized personal health record data to assess humanistic and economic impacts across various demographics.
Findings indicate that hematologic malignancies significantly affect patients' financial stability and overall well-being throughout their treatment journey.
The study emphasizes the need for better support systems for individuals affected by these disorders, especially in resource-limited settings.